Leptin-immune activation and its role in the development of T2D and its associated major adverse cardiovascular events represent a promising new area for research (summary of the actions of adipocytokine on immune cells is detailed in Figure 1). This evidence concerns the gene LEP and type 2 diabetes mellitus.